CFR Q1 2026 Earnings Solid EPS Beat Amid Stable Performance CXApp Inc CXAI Q1 2026 Earnings EPS Surprises Positively Amid Revenue Uncertainty Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline CHA Q4 2025 Earnings EPS Misses Estimates by Wide Margin VeriSign Holds Steady Above 309 After Modest Gain CanVRSN Sustain Momentum Central Pacific Financial CPF Holds Steady Near Support Amid Modest Pullback OKYO Pharma Shares Edge Higher as Biotech Momentum Builds Precision Drilling PDS Slides 385 Key Support Levels in Focus ROP Q1 2026 Earnings EPS Surpasses Estimates by 258 Amid Market Headwinds